
Jonathan Ian Silverberg MD
Associate Professor of Dermatology, George Washington University School of Medicine and Health Sciences
Join to view full profile
2150 Pennsylvania Ave NWSte 2B-430Washington, DC 20037
Phone+1 202-741-2625
Dr. Silverberg is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jonathan Silverberg is a dermatologist in Washington, DC and is affiliated with George Washington University School of Medicine and Health Sciences. He received his medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 8 years. He is experienced in general dermatology, atopic dermatitis, contact dermatitis, allergic contact dermatitis, and eczema.
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Dermatology, 2010 - 2013
SUNY Downstate Health Sciences UniversityInternship, Internal Medicine, 2009 - 2010
State University of New York Downstate Medical Center College of MedicineClass of 2009
Certifications & Licensure
OR State Medical License 2012 - Present
IL State Medical License 2013 - 2029
DC State Medical License 2019 - 2028
MD State Medical License 2019 - 2021
NY State Medical License 2012 - 2014
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Northwestern Meaningful Use Data Warehouse Application for Eligible Providers, Northwestern University, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification PowerChart (Clinical), Cerner Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Northwestern Meaningful Use Data Warehouse Application for Eligible Providers, Northwestern University, 2014, 2016-2017
Publications & Presentations
PubMed
- Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary.Eric Simpson, Lawrence F Eichenfield, Kim A Papp, Seth B Forman, Adelaide A Hebert
The Journal of Dermatological Treatment. 2026-12-01 - Guidelines for diagnostic testing in adults with presumed atopic dermatitis refractory to treatment.Robert Sidbury, Peggy A Wu, Ali Alikhan, Lionel Bercovitch, David E Cohen
Journal of the American Academy of Dermatology. 2026-11-01 - Development of a Conceptual Disease Model of Atopic Dermatitis Using Data from the Phase 3 ARCADIA 1 Trial.Jonathan I Silverberg, Patrick Daniele, Danielle Rodriguez, Sarah Mulnick, Gil Yosipovitch
Dermatology and Therapy. 2026-11-01
Journal Articles
- Efficacy and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic DermatitisJonathan I Silverberg, Eric L Simpson, Hernan Valdez, JAMA Dermatology
- Dupilumab Provides Important Clinical Benefits to Patients with Atopic Dermatitis Who Do Not Achieve Clear or Almost Clear Skin According to the Investigator's Global ...J I Silverberg, The British Journal of Dermatology
- Inpatient Burden of Juvenile Dermatomyositis Among Children in the United StatesMichael C Kwa, Jonathan I Silverberg, BioMed Central
Authored Content
- Efficacy and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic DermatitisJune 2020
Press Mentions
Castle Biosciences Launches Test to Guide Atopic Dermatitis Treatment SelectionNovember 12th, 2025
Castle Biosciences Launches AdvanceAD-Tx™ to Help Guide Systemic Treatment Decision Making in Patients with Moderate-to-Severe Atopic DermatitisNovember 3rd, 2025
New Analysis of 13,560 Patients Demonstrates DecisionDx®-Melanoma Stratifies Risk Across Histological Subtypes; Findings to Be Presented at Fall Clinical Dermatology ConferenceOctober 24th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: